Netherlands: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Netherlands

The Dutch human and animal blood market reduced rapidly to $X in 2022, shrinking by X% against the previous year. Overall, the total consumption indicated measured growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2019 indices. Human and animal blood consumption peaked at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Netherlands

In value terms, human and animal blood production declined to $X in 2022 estimated in export price. Overall, production, however, continues to indicate tangible growth. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. Human and animal blood production peaked at $X in 2018; however, from 2019 to 2022, production failed to regain momentum.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from the Netherlands

In 2022, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported from the Netherlands; picking up by X% compared with 2021. Over the period under review, exports enjoyed significant growth. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. The exports peaked in 2022 and are expected to retain growth in years to come.

In value terms, human and animal blood exports rose rapidly to $X in 2022. Overall, exports recorded significant growth. The most prominent rate of growth was recorded in 2014 when exports increased by X% against the previous year. Over the period under review, the exports attained the peak figure in 2022 and are expected to retain growth in the near future.

Exports by Country

India (X tons) was the main destination for human and animal blood exports from the Netherlands, accounting for a X% share of total exports. Moreover, human and animal blood exports to India exceeded the volume sent to the second major destination, France (X tons), twofold. Germany (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to India amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (X% per year) and Germany (X% per year).

In value terms, India ($X) emerged as the key foreign market for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports from the Netherlands, comprising X% of total exports. The second position in the ranking was taken by France ($X), with a X% share of total exports. It was followed by Germany, with an X% share.

From 2012 to 2022, the average annual growth rate of value to India stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (X% per year) and Germany (X% per year).

Export Prices by Country

In 2022, the average human and animal blood export price amounted to $X per ton, reducing by X% against the previous year. In general, the export price recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2020 an increase of X%. The export price peaked at $X per ton in 2021, and then reduced remarkably in the following year.

There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to Russia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the UK (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into the Netherlands

In 2022, after two years of growth, there was significant decline in supplies from abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume decreased by X% to X tons. Over the period under review, imports, however, continue to indicate a buoyant expansion. The growth pace was the most rapid in 2013 when imports increased by X%. Over the period under review, imports attained the peak figure at X tons in 2021, and then declined in the following year.

In value terms, human and animal blood imports skyrocketed to $X in 2022. In general, imports, however, saw a strong increase. The pace of growth appeared the most rapid in 2013 with an increase of X%. Over the period under review, imports hit record highs in 2022 and are expected to retain growth in the immediate term.

Imports by Country

The United States (X tons), South Korea (X tons) and Germany (X tons) were the main suppliers of human and animal blood imports to the Netherlands, together comprising X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by South Korea (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X), South Korea ($X) and the United States ($X) constituted the largest human and animal blood suppliers to the Netherlands, together accounting for X% of total imports.

South Korea, with a CAGR of X%, recorded the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2022, rising by X% against the previous year. Overall, import price indicated resilient growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 an increase of X% against the previous year. The import price peaked in 2022 and is likely to see steady growth in the immediate term.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :